2019 (66 POSTS)
Thompson CM , Fitch SE , Ring C, Rish W , Cullen JM, Haws LC . 2019. Development of an oral reference dose for the perfluorinated compound GenX. J Appl Toxicol 39(9):1267–1282; doi: 10.1002/jat.3812 . PMID: 31215065.
View Abstract
Topics: benchmark dose estimation (BMD) , PFAS , water
Wikoff D , Haws L , Ring C, Budinsky R. 2019. Application of qualitative and quantitative uncertainty assessment tools in developing ranges of plausible toxicity values for 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin. J Appl Toxicol 39(9):1293-1310; doi: 10.1002/jat.3814 . PMID: 31257608.
View Abstract
Topics: dioxin , risk assessment
Frankenfeld CL , Leslie TF. 2019. Descriptive epidemiology of homicides with victim and suspect race or Hispanic ethnicity discordance in the United States: Analysis of National Violent Death Reporting System (NVDRS) 2005-2015. J Interpers Violence 36(17-18):NP9693–NP9173; doi: 10.1177/0886260519861656 . PMID: 31288601.
View Abstract
Topics: community health , Epidemiology
Hoff CE, Movva N , Rosen Vollmar AK, Pérez-Escamilla R. 2019. Impact of maternal anxiety on breastfeeding outcomes: A systematic review. Advanc Nutr 10(5):816-826; doi: 10.1093/advances/nmy132 . PMID: 31079143.
View Abstract
Topics: nutrition , Systematic Review
Nordyke RJ , Reichert H , Bylsma LC , Jackson JJ, Gage SM, Fryzek J, Roy-Chaudhury P, Lithgow T. 2019. Costs attributable to arteriovenous fistula and arteriovenous graft placements in hemodialysis patients with Medicare coverage. Am J Nephrol 50(4):320-328; doi: 10.1159/000502507 . PMID: 31434095.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Bussiere JL, Davies R, Dean C, Xu C, Kim KH, Vargas HM, Chellman GJ, Balasubramanian G, Monticello TM . 2019. Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine. Regul Toxicol Pharmacol 106(Aug):224-238; doi: 10.1016/j.yrtph.2019.05.013 . PMID: 31085251.
View Abstract
Topics: nonclinical safety assessment
Webster F, Gagne M, Patlewicz G , Pradeep P, Trefiak N, Judson R, Barton-Maclaren TS. 2019. Predicting estrogen receptor activation by a group of substituted phenols: An integrated approach to testing and assessment case study. Regul Toxicol Pharmacol 106(Aug):278-291; doi: 10.1016/j.yrtph.2019.05.017 . PMID: 31121201.
View Abstract
Topics: NAMs
Patlewicz G , Lizarraga L, Rua D, Allen DG, Daniel A, Fitzpatrick SC, Garcia-Reyero N, Gordon J, et al. 2019. Exploring current read-across applications and needs among selected US federal agencies. Regul Toxicol Pharmacol 106(Aug):197-209; doi: 10.1016/j.yrtph.2019.05.011 . PMID: 31078681.
View Abstract
Topics: NAMs
Danese MD, Katz A, Cetin K, Chia V, Gleeson ML, Kelsh M , et al. 2019. Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: An observational cohort study using SEER Medicare data. Leuk Lymphoma 60(8):2015–2024; doi: 10.1080/10428194.2018.1555329 . PMID: 30632830.
View Abstract
Topics: Cancer
Andersen ME, Gentry PR, Swenberg JA, Mundt KA, White KW, Thompson C , Bus J, Sherman JH, et al. 2019. Considerations for refining the risk assessment process for formaldehyde: Results from an interdisciplinary workshop. Regul Toxicol Pharmacol 106(Aug):210–223; doi: 10.1016/j.yrtph.2019.04.015 . PMID: 31059732.
View Abstract
Topics: formaldehyde , risk assessment
Prior H, Monticello T , Boulifard V, Brennan FR, Kimber I. 2019. Integration of consortia recommendations for justification of animal use within current and future drug development paradigms. Int J Toxicol 38(4):319-325; doi: 10.1177/1091581819852922 . PMID: 31220983.
View Abstract
Topics: drug development , safety assessment
Frankenfeld CL , Leslie TF. 2019. County-level socioeconomic factors and residential racial, Hispanic, poverty, and unemployment segregation associated with drug overdose deaths in the United States, 2010–2015. Ann Epidemiol 35(July):12–19; doi: 10.1016/j.annepidem.2019.04.009 . PMID: 31080000.
View Abstract
Topics: community health , Epidemiology
Klaren WD , Ring C, Harris MA, Thompson CM , Borghoff S , Sipes NS, Hsieh JH, Auerbach SS, Rager JE. 2019. Identifying attributes that influence in vitro-to-in vivo concordance by comparing Tox21 bioactivity versus DrugMatrix transcriptomic responses across 130 chemicals. Toxicol Sci 167(1):157–171; doi: 10.1093/toxsci/kfy220 . PMID: 30202884.
View Abstract